Position in MTD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$496,951
+$42,919 QoQ
Shares Held
389
+8.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#488
of 799 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MTD Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SYON CAPITAL LLC holds $11,119,149 across 14 Diagnostics & Research names. MTD ranks #10 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,474 | $1,741,724 | |
| 2 | ILMN |
Illumina, Inc.
|
8,606 | $1,513,192 | |
| 3 | DHR |
Danaher Corp /De/
|
6,884 | $1,311,264 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,668 | $878,101 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
3,547 | $804,424 | |
| 6 | A |
Agilent Technologies, Inc.
|
5,976 | $793,792 | |
| 7 | DGX |
Quest Diagnostics Inc
|
3,595 | $761,960 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
3,518 | $679,747 |
All Filings in MTD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,951 | 389 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $454,032 | 360 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $584,165 | 419 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $335,137 | 273 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $236,118 | 201 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $357,815 | 303 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $250,854 | 205 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $296,940 | 198 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $276,722 | 198 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $206,349 | 155 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $264,828 | 239 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||